Hennepolie.nl - Hemp oil and CBD oil products
Denmark extends trial for cannabis patients by 4 years and makes production permanent – ​​Drugs Inc.eu
Home CannabisDenmark extends trial for cannabis patients by 4 years and makes production permanent

Denmark extends trial for cannabis patients by 4 years and makes production permanent

by druginc
Denmark extends trial for cannabis patients by 4 years and makes production permanent

The Danish government has extended the medical cannabis pilot program in Denmark for another four years.

The current scheme, which began in January 2018, was intended to be a four-year trial of a legal system for medicinal cannabis. Many Danish companies have been licensed to grow medical grade cannabis and a new legal infrastructure has allowed prescriptions for Danish patients.

Denmark opened in 2018 access to medical cannabis for patients as part of a four-year pilot program. The aim is to provide patients with legal, safe products and to provide national health authorities with patient data.


That information had to be analyzed to understand use and efficacy at the end of the trial period to consider establishing a permanent medical market, but a permanent domestic plan has not yet been named.

Only patients with multiple sclerosis, spinal cord injury, cancer and neuropathic pain are eligible for the program.

The trial was set to end in December this year, but in a press statement on May 25, the Danish government announced last week that parts of the scheme will be extended.


Danish doctors will retain the option to prescribe medicinal cannabis to patients for at least another four years, while farms will be allowed to grow cannabis for medicinal use on a permanent basis.

Extended for four years

“The government (Social Democrats), the Liberals, the Danish People's Party, the Socialist People's Party, the Unity List, the New Bourgeois, the Liberal Alliance, the Alternative, the Christian Democrats and the Free Greens have decided to continue the pilot scheme with medical cannabis," reads the government's press statement.

In order to realize this extension, the cabinet plans to submit a number of bills later in the year, which must be adopted before the end of 2021.


Responses from companies such as DanCann Pharma, a Danish medical cannabis company, are clear:

“We welcome the decision of the Danish Parliament to expand the pilot program that will enable local cultivation and production of medicinal cannabis,” said Jeppe Krog Rasmussen, CEO of the company DanCann Pharma. He continued: “Having said that, we must not forget our Danish patients. Despite this extension of a 4-year trial period for prescribing medicinal cannabis in Denmark, nothing has changed in the legal framework regarding conditions. This is just not good enough, we will continue to fight for this as always and we will also demand better conditions.”

Low use of medicinal cannabis in Denmark, but growing cultivation

Despite the fact that Denmark has a large number of recognized medical cannabis companies, like many other countries in Europe – still a small and limited community of cannabis patients. Currently, only four products – all imported from other countries – are allowed by the Danish Medicines Agency for use in the pilot program – but these are rarely prescribed by Danish doctors.

Low use of medicinal cannabis in Denmark, but growing cultivation (fig)
Low use of medicinal cannabis in Denmark, but growing cultivation (afb)

“Medical cannabis is currently used by approximately 1.500 patients (about 3.000 prescriptions) on a quarterly basis,” Rasmussen said earlier this year. “However, on the patient side, we see very frightening numbers – namely approximately 80 percent of patients who have used or are still using cannabis have bought it through the illicit market outside their doctor's supervision. “This is due to the continued highly latent market we are seeing for products with us in Denmark,” he added, “as well as the expensive prices and doctors uncooperative for various reasons.”

But while recipes were scarce during the trial, cultivation permits were rife. About 47 cannabis companies have been licensed and about 15 have continued to build facilities and grow the cannabis crops.


“The political system has chosen to create lucrative conditions for new medical cannabis producers in Denmark, where we do not have a higher production capacity and also have access to exports as one of the still very few countries in Europe. And for the same reason, we have seen huge investments and large joint ventures in this new market for medicinal cannabis.”

Sources include AnalyticalCannabis (EN), Cannabis Wealth (EN), Muggle Head (EN), mmy (EN)

Related Articles

Leave a comment